Cargando…
What Happens to the Immune Microenvironment After PD-1 Inhibitor Therapy?
The fruitful results of tumor immunotherapy establish its indispensable status in the regulation of the tumorous immune context. It seems that the treatment of programmed cell death receptor 1 (PD-1) blockade is one of the most promising approaches for cancer control. The significant efficacy of PD-...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733588/ https://www.ncbi.nlm.nih.gov/pubmed/35003090 http://dx.doi.org/10.3389/fimmu.2021.773168 |